Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision history update: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the government funding lapse notice from the page; trial details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedNo significant additions or deletions were detected on the page. The study overview and key sections remain unchanged.SummaryDifference0.3%

- Check63 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. If no other substantive content changed, this is a minor but status/reliability-related update.SummaryDifference2%

- Check70 days agoChange DetectedAdded extensive contact details (phones/emails) and a new version tag; removed a specific resource entry about head and neck squamous cell carcinoma. Overall, a shift toward updating people/organization identifiers and versioning, with a minor removal of a resource reference.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page is updated to revision v3.0.2 (replacing v3.0.1); the 'Back to Top' element has been removed as a minor UI change.SummaryDifference0.1%

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.